A Spark of Hope Against Sickle-Cell

A sickle-cell drug common to wealthy countries has been deemed safe to use in Africa, home to 75% of babies born with the condition each year.

Hydroxyurea is cheap, effective and easily administered against the painful and potentially deadly condition.

But previous research had sparked concern that, if deployed in Africa, the drug could up the risk of local infections like malaria. This new research concluded the opposite, finding children were half as likely to contract malaria while using it.

There’s more work to be done, the researchers note, such as finding the ideal dosage and determining the drug’s long-term effects.

The New York Times

Secondary Topic
Comments +


Post a Comment

Restricted HTML

  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Back to top